Literature DB >> 17615584

The diabetogenic, insulin-specific CD8 T cell response primed in the experimental autoimmune diabetes model in RIP-B7.1 mice.

Wolfram Karges1, Tarvo Rajasalu, Andreas Spyrantis, Andreas Wieland, Bernhard Boehm, Reinhold Schirmbeck.   

Abstract

Type 1 diabetes mellitus can result from the specific destruction of pancreatic beta cells by autoreactive T cells. As shown here, experimental autoimmune diabetes (EAD) is efficiently induced in RIP-B7.1 mice by preproinsulin (ppins)-encoding DNA vaccines. EAD develops in RIP-B7.1 mice within 3-4 wk after a single immunization with ppins-encoding plasmid DNA. RIP-B7.1 mice develop insulitis, insulin deficiency and hyperglycemia after vaccination with plasmids encoding murine ppins-I or murine ppins-II or human hu-ppins. EAD induction critically depends on CD8 T cells and is independent of CD4 T cells. To be diabetogenic, ppins-specific CD8 T cells had to express IFN-gamma. Neither expression of perforin nor signaling through the type I IFN receptor is an essential component of this pathogenic CD8 T cell phenotype. Using plasmids encoding truncated ppins variants, we show that EAD is only induced by DNA vaccines encoding the insulin A-chain. Diabetogenic CD8 T cells specifically recognize the Kb-restricted A12-21 epitope of the insulin A-chain. The RIP-B7.1 model hence represents an attractive model for the characterization of cellular and molecular events involved in the CD8 T cell-mediated immune pathogenesis of diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17615584     DOI: 10.1002/eji.200737222

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responses.

Authors:  Deanna Lamont; Gayatri Mukherjee; P Rajesh Kumar; Dibyendu Samanta; Caroline G McPhee; Thomas W H Kay; Steven C Almo; Teresa P DiLorenzo; David V Serreze
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

2.  Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases.

Authors:  Dietmar M W Zaiss; Cornelis P J Bekker; Andrea Gröne; Benedicte A Lie; Alice J A M Sijts
Journal:  J Immunol       Date:  2011-07-29       Impact factor: 5.422

3.  Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin.

Authors:  Irene Jarchum; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

4.  Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.

Authors:  Tarvo Rajasalu; Helen Brosi; Cornelia Schuster; Andreas Spyrantis; Bernhard Otto Boehm; Lieping Chen; Jörg Reimann; Reinhold Schirmbeck
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

5.  beta-Cells step up in controlling the autoimmune response.

Authors:  Paolo Fiorina
Journal:  Diabetes       Date:  2010-08       Impact factor: 9.461

6.  Pancreatic alpha-cell mass in the early-onset and advanced stage of a mouse model of experimental autoimmune diabetes.

Authors:  Eva Bru-Tari; Nadia Cobo-Vuilleumier; Paloma Alonso-Magdalena; Reinaldo S Dos Santos; Laura Marroqui; Angel Nadal; Benoit R Gauthier; Ivan Quesada
Journal:  Sci Rep       Date:  2019-07-02       Impact factor: 4.379

7.  A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.

Authors:  Cornelia Schuster; Helen Brosi; Katja Stifter; Bernhard O Boehm; Reinhold Schirmbeck
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

8.  PAX4 preserves endoplasmic reticulum integrity preventing beta cell degeneration in a mouse model of type 1 diabetes mellitus.

Authors:  José Manuel Mellado-Gil; Carmen María Jiménez-Moreno; Alejandro Martin-Montalvo; Ana Isabel Alvarez-Mercado; Esther Fuente-Martin; Nadia Cobo-Vuilleumier; Petra Isabel Lorenzo; Eva Bru-Tari; Irene de Gracia Herrera-Gómez; Livia López-Noriega; Javier Pérez-Florido; Javier Santoyo-López; Andreas Spyrantis; Paolo Meda; Bernhard O Boehm; Ivan Quesada; Benoit R Gauthier
Journal:  Diabetologia       Date:  2016-01-26       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.